RYR2 and catecholaminergic polymorphic ventricular tachycardia: Most important, and among the several CPVT disease modeling studied, we found a novel RyR2 macromolecular complex remodeling for the first time using hiPSC-CMs which could explain the pharmacological responses observed clinically.